Back to top

INSYS Therapeutics (INSY) in Focus: Stock Rises 5.5%
May 19, 2014

Read MoreHide Full Article
INSYS Therapeutics, Inc. (INSY - Free Report) was a big mover last session with its shares rising nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company as the stock has lost over 42% since May 1.

This specialty pharmaceutical company has seen one negative estimate revision in the last 30 days. The Zacks Consensus Estimate has also moved lower over the same period. This implies trouble down the road. So make sure to keep an eye on this stock going forward to see if Friday’s rally can last.

INSYS Therapeutics currently holds a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Investors interested in the Medical Products industry may consider better-ranked stocks like Cardica Inc. , ICU Medical, Inc. (ICUI - Free Report) and Mead Johnson Nutrition Company . All three stocks bear a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Insys Therapeutics, Inc. (INSY) - free report >>

ICU Medical, Inc. (ICUI) - free report >>


More from Zacks Tale of the Tape

You May Like